LB
NVO

Leo Brokerage’s Novo Nordisk NVO Stock Holding History

Leo Brokerage’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$408K Sell
5,038
-54
-1% -$4.41K 0.05% 208
2023
Q1 		$405K Buy
+5,092
New +$361K 0.06% 199
2022
Q2 		– Sell
-5,192
Closed -$289K – 234
2022
Q1 		$289K Buy
+5,192
New +$266K 0.05% 197

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Leo Brokerage's NVO Position: Q2 2023 in Review

Leo Brokerage reduced its Novo Nordisk (NVO) stake by 1.1% in Q2 2023, selling an estimated $4.41K and leaving 5,038 shares worth $408K. The position accounts for 0.05% of the portfolio, ranked #208.

Leo Brokerage first reported a position in NVO in Q1 2022 and has held it in 3 quarters since. 1,197 funds tracked by Wall St. Rank hold NVO as of Q2 2023.

  • Leo Brokerage held 5,038 shares of Novo Nordisk worth $408K as of Q2 2023.
  • Leo Brokerage sold 54 Novo Nordisk shares in Q2 2023, an estimated $4.41K.
  • Novo Nordisk made up 0.05% of Leo Brokerage's portfolio in Q2 2023, its #208 holding.
  • Leo Brokerage first reported a position in Novo Nordisk in Q1 2022 and has held it in 3 quarters since.
  • 1,197 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.

Based on Leo Brokerage's 13F filing for Q2 2023, filed 25 Jul 2023.